Revenue
attach_money0M USD
-
ACRVAcrivon Therapeutics, Inc. Common Stock$ --
Acrivon Therapeutics, Inc. Common Stock
ACRV
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-20M USD
-
Net Income
verified-19M USD
-
EPS
paid-0.49$
-
Revenue
$0
MISS
Q1
Q2
Q3
$166,286
$166,286
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$-19M
MISS
$-19.7M
$-21M
$-22.8M
$-18.2M
$-18.6M
$-19M
$-41.4M
$-77.9M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025MISS